Neuroprotective Mechanisms of PPARδ: Modulation of Oxidative Stress and Inflammatory Processes.
paper
Cited
Public
- Authors
- Schnegg, Caroline I; Robbins, Mike E
- Year
- 2011
- Journal
- PPAR research
- PMID
- 22135673
- DOI
- 10.1155/2011/373560
- PMCID
- PMC3205692
Peroxisome proliferator-activated receptors (PPARα, δ, and γ) are ligand-activated transcription factors that regulate a wide range of cellular processes, including inflammation, proliferation, differentiation, metabolism, and energy homeostasis. All three PPAR subtypes have been identified in the central nervous system (CNS) of rodents. While PPARα and PPARγ are expressed in more restricted areas of the CNS, PPARδ is ubiquitously expressed and is the predominant subtype. Although data regarding PPARδ are limited, studies have demonstrated that administration of PPARδ agonists confers neuroprotection following various acute and chronic injuries to the CNS, such as stroke, multiple sclerosis, and Alzheimer's disease. The antioxidant and anti-inflammatory properties of PPARδ agonists are thought to underly their neuroprotective efficacy. This review will focus on the putative neuroprotective benefits of therapeutically targeting PPARδ in the CNS, and specifically, highlight the antioxidant and anti-inflammatory functions of PPARδ agonists.
No figures extracted from this document.
1–20 of 34
Next →
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans. | 2015 | 25516156 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Berberine: An isoquinoline alkaloid targeting the oxidative stress and gut-brain axis in the models of depression. | Chen CY et al. | — | 2025 | → |
| Peroxisome proliferator-activated receptors (PPARs) agonists as promising neurotherapeutics. | Ghannam IAY et al. | — | 2025 | → |
| Potentials of peroxisome proliferator-activated receptor (PPAR) α, β/δ, and γ: An in-depth and comprehensive review of their molecular mechanisms, cellular Signalling, immune responses and therapeutic implications in multiple diseases. | Singh A et al. | — | 2025 | → |
| Recent Insights on the Role of Nuclear Receptors in Alzheimer's Disease: Mechanisms and Therapeutic Application. | Shan X et al. | — | 2025 | → |
| Treadmill Exercise Modulates the Leptin/LepR/GSK-3β Signalling Pathway to Improve Leptin Sensitivity and Alleviate Neuroinflammation in High-Fat Diet-Fed APP/PS1 Mice. | Wang J et al. | — | 2025 | → |
| Highly potent and selective PPARδ agonist reverses memory deficits in mouse models of Alzheimer's disease. | Kim HJ et al. | — | 2024 | → |
| Novel PPAR-γ agonists as potential neuroprotective agents against Alzheimer's disease: rational design, synthesis<i>, in silico</i> evaluation, PPAR-γ binding assay and transactivation and expression studies. | D P et al. | — | 2024 | → |
| Saroglitazar, a PPAR α/γ agonist alleviates 3-Nitropropionic acid induced neurotoxicity in rats: Unveiling the underlying mechanisms. | Jakkamsetti MS et al. | — | 2024 | → |
| Cellular and Molecular Regulation of Exercise-A Neuronal Perspective. | Reddy I et al. | — | 2023 | → |
| High glucose inhibits neural differentiation by excessive autophagy <em>via</em> peroxisome proliferator-activated receptor gamma. | Pan Y et al. | — | 2023 | → |
| Identification of molecular network of gut-brain axis associated with neuroprotective effects of PPARδ-ligand erucic acid in rotenone-induced Parkinson's disease model in zebrafish. | Ünal İ et al. | — | 2023 | → |
| Peroxisomal Proliferator-Activated Receptor <i>β</i>/<i>δ</i> Deficiency Induces Cognitive Alterations. | Espinosa-Jiménez T et al. | — | 2022 | → |
| The Potential Role of PPARs in the Fetal Origins of Adult Disease. | Guo J et al. | — | 2022 | → |
| Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy. | Strosznajder AK et al. | — | 2021 | → |
| Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders. | Sanjay et al. | — | 2021 | → |
| Tonic Endocannabinoid Signaling Gates Synaptic Plasticity in Dorsal Raphe Nucleus Serotonin Neurons Through Peroxisome Proliferator-Activated Receptors. | Oubraim S et al. | — | 2021 | → |
| Comparison of PPAR Ligands as Modulators of Resolution of Inflammation, via Their Influence on Cytokines and Oxylipins Release in Astrocytes. | Chistyakov DV et al. | — | 2020 | → |
| GW0742 activates miR-17-5p and inhibits TXNIP/NLRP3-mediated inflammation after hypoxic-ischaemic injury in rats and in PC12 cells. | Gamdzyk M et al. | — | 2020 | → |
| Role of peroxisome proliferator-activated receptors in stroke prevention and therapy-The best is yet to come? | Gamdzyk M et al. | — | 2020 | → |
| Activation of PPARγ Attenuates the Expression of Physical and Affective Nicotine Withdrawal Symptoms through Mechanisms Involving Amygdala and Hippocampus Neurotransmission. | Domi E et al. | — | 2019 | → |
| PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease. | Chen L et al. | — | 2019 | → |
| Oral administration of a novel lipophilic PPARδ agonist is not neuroprotective after rodent cerebral ischemia. | Knauss S et al. | — | 2018 | → |
| Role of PPAR-β/δ/miR-17/TXNIP pathway in neuronal apoptosis after neonatal hypoxic-ischemic injury in rats. | Gamdzyk M et al. | — | 2018 | → |
| Therapeutic Advantages of Dual Targeting of PPAR-δ and PPAR-γ in an Experimental Model of Sporadic Alzheimer's Disease. | Reich D et al. | — | 2018 | → |
| Anti-inflammatory mechanism of galangin in lipopolysaccharide-stimulated microglia: Critical role of PPAR-γ signaling pathway. | Choi MJ et al. | — | 2017 | → |
| Changes in PPARδ expression in a rat model of stress-induced depression. | Liu KF et al. | — | 2017 | → |
| PPARs in the central nervous system: roles in neurodegeneration and neuroinflammation. | Zolezzi JM et al. | — | 2017 | → |
| A Brief Discussion on Lipid Activated Nuclear Receptors and their Potential Role in Regulating Microglia in Age-Related Macular Degeneration (AMD). | Choudhary M et al. | — | 2016 | → |
| Genetic Deletion of Neuronal PPARγ Enhances the Emotional Response to Acute Stress and Exacerbates Anxiety: An Effect Reversed by Rescue of Amygdala PPARγ Function. | Domi E et al. | — | 2016 | → |
| Neuroprotective effects of sodium hydrosulfide against β-amyloid-induced neurotoxicity. | Li XH et al. | — | 2016 | → |
| PPARβ/δ selectively regulates phenotypic features of age-related macular degeneration. | Choudhary M et al. | — | 2016 | → |
| Prenatal fat exposure and hypothalamic PPAR β/δ: Possible relationship to increased neurogenesis of orexigenic peptide neurons. | Chang GQ et al. | — | 2016 | → |
| Rethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal Diseases. | Choudhary M et al. | — | 2016 | → |
| Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ. | Tan NS et al. | — | 2016 | → |
| Consequences of low dose ionizing radiation exposure on the hippocampal microenvironment. | Acharya MM et al. | — | 2015 | → |
| Development of telmisartan in the therapy of spinal cord injury: pre-clinical study in rats. | Lin CM et al. | — | 2015 | → |
| Modulation of the Nitrergic Pathway via Activation of PPAR-γ Contributes to the Neuroprotective Effect of Pioglitazone Against Streptozotocin-Induced Memory Dysfunction. | Prakash A et al. | — | 2015 | → |
| Nutrition facts in multiple sclerosis. | Riccio P et al. | — | 2015 | → |
| Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans. | Blednov YA et al. | — | 2015 | → |
| The effect of neuronal conditional knock-out of peroxisome proliferator-activated receptors in the MPTP mouse model of Parkinson's disease. | Mounsey RB et al. | — | 2015 | → |
| Variable telomere length across post-mortem human brain regions and specific reduction in the hippocampus of major depressive disorder. | Mamdani F et al. | — | 2015 | → |
| Decrease of PPARδ in Type-1-Like Diabetic Rat for Higher Mortality after Spinal Cord Injury. | Tsai CC et al. | — | 2014 | → |
| Effects of ionizing radiation on biological molecules--mechanisms of damage and emerging methods of detection. | Reisz JA et al. | — | 2014 | → |
| Physiological functions of peroxisome proliferator-activated receptor β. | Neels JG et al. | — | 2014 | → |
| PPARδ binding to heme oxygenase 1 promoter prevents angiotensin II-induced adipocyte dysfunction in Goldblatt hypertensive rats. | Sodhi K et al. | — | 2014 | → |
| Regulation of peroxisome proliferator-activated receptor β/δ expression and activity levels by toll-like receptor agonists and MAP kinase inhibitors in rat astrocytes. | Chistyakov DV et al. | — | 2014 | → |
| Expression profiles of the nuclear receptors and their transcriptional coregulators during differentiation of neural stem cells. | Androutsellis-Theotokis A et al. | — | 2013 | → |
| Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia. | Freilich RW et al. | — | 2013 | → |
| Nitric oxide donors as neuroprotective agents after an ischemic stroke-related inflammatory reaction. | Godínez-Rubí M et al. | — | 2013 | → |
| Peroxisome proliferator-activated receptor (PPAR)β/δ, a possible nexus of PPARα- and PPARγ-dependent molecular pathways in neurodegenerative diseases: Review and novel hypotheses. | Aleshin S et al. | — | 2013 | → |
| Pulmonary phthalate exposure and asthma - is PPAR a plausible mechanistic link? | Kocbach Bølling A et al. | — | 2013 | → |
| Neuron-specific deletion of peroxisome proliferator-activated receptor delta (PPARδ) in mice leads to increased susceptibility to diet-induced obesity. | Kocalis HE et al. | — | 2012 | → |